This finding aligns with existing literature, which indicates that CD4+ and CD8+ T‐cell responses in convalescent COVID‐19 patients or recipients of the COVID‐19 mRNA vaccines were not significantly impacted by mutations present in SARS‐CoV‐2 variants.72 This evidence concerns the gene CD4 and COVID-19.